Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-04-12

Clinical Trial Update: A Study of Caldolor in Hospitalized Febrile Pediatric Patients [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating Caldolor (ibuprofen) for fever in hospitalized febrile pediatric patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CALDOLOR (Ibuprofen)

Snippet

Sponsor: Cumberland Pharmaceuticals | Conditions: Fever | Phase 3 | Status: COMPLETED